PhaseV is developing a unique set of advanced technologies and innovative statistical methods to revolutionize trial design, execution, and analysis.
Unlocking the potential of adaptive clinical trials with an intuitive ML-based platform.
Harness the power of advanced causal inference and cutting-edge ML to detect hidden signals in clinical data and extract clinically meaningful insights.
| Product | Market Share (%) |
|---|---|
| PhaseV | 0.2% |
| PTC Windchill | 17.2% |
| Siemens PLM TeamCenter | 16.6% |
| Other | 66.0% |
We have not yet collected reviews for PhaseV. Share your experience with PeerSpot's community.
Share a review
